IRCT20230813059134N1招募中3 期
the effect of empagliflozin on control of seizure attacks in patients with drug-resistance epilepsy
euroscience Research Center of Imam Khomeini hospital0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 45 years（—）
- 性别
- All
入选标准
- •Patients who have drug-resistant epilepsy and have tried two insufficient and different medical treatment
- •Age between 18 to 45
排除标准
- •Other neurological disorders
- •Metabolic disorders
- •Dyslipidemia
- •Kidney diseases
- •Active infection
- •Patient refuse to continue the study
- •Showing the unregistered side effects of drug
- •BMI more than 30 and less than 18.5
- •Non- compliant patients
- •Patients with ketogenic diet
- •Patients with carbonic anhydrase inhibitor medication
研究者
相似试验
招募中
2 期
Evaluation of the effect of empagliflozin on prevention of atrial fibrillation after heart surgeryAtrial fibrillation after heart surgery.Paroxysmal atrial fibrillationIRCT20120520009801N9Mashhad University of Medical Sciences160
尚未招募
3 期
Evaluation of the effect of Empagliflozin on the severity of heart failure symptoms and echocardiography parameters in patients with congenital heart diseases with left-to-right shuntIRCT20120520009801N11Mashhad University of Medical Sciences44
招募中
4 期
A study examining the effects of empagliflozin (Jardiance®), a tablet for treatment of diabetes on autonomic nervous system and heart function in patients with type 2 diabetes.Metabolic and Endocrine - DiabetesCardiovascular - Normal development and function of the cardiovascular systemType 2 DiabetesACTRN12619000887178Baker Heart and Diabetes Institute60
尚未招募
3 期
The effect of empagliflozin on reduction of cardiovascular complication after PCIType 2 diabetes mellitus.Diabetes mellitus due to underlying conditionIRCT20210612051550N1Ahvaz University of Medical Sciences100
招募中
3 期
Evaluating the effects of empagliflozin in preventing myocardial damage in patients undergoing percutaneous coronary interventioCardiovascular disease.Cardiovascular disease, unspecified429.2IRCT20221102056378N1Tabriz University of Medical Sciences90